{
  "Alkylating Agents & DNA Crosslinkers": [
    "Cyclophosphamide",
    "Chlorambucil",
    "Busulfan",
    "Cisplatin",
    "Carboplatin",
    "Oxaliplatin",
    "Lomustine",
    "Mechlorethamine Hydrochloride",
    "Procarbazine Hydrochloride",
    "Bendamustine Hydrochloride"
  ],
  "Antimetabolites": [
    "Fluorouracil",
    "Capecitabine",
    "Cytarabine",
    "Gemcitabine Hydrochloride",
    "Methotrexate",
    "Pemetrexed Disodium",
    "Decitabine",
    "Fludarabine Phosphate",
    "Dacarbazine"
  ],
  "Topoisomerase Inhibitors": [
    "Etoposide",
    "Etoposide Phosphate",
    "Irinotecan Hydrochloride"
  ],
  "Antimicrotubule Agents": [
    "Paclitaxel",
    "Docetaxel",
    "Vinblastine Sulfate",
    "Vincristine Sulfate",
    "Vinorelbine Tartrate"
  ],
  "Hormonal / Endocrine Therapies": [
    "Tamoxifen Citrate",
    "Anastrozole",
    "Letrozole",
    "Exemestane",
    "Abiraterone Acetate",
    "Bicalutamide",
    "Megestrol Acetate",
    "Leuprolide Acetate",
    "Degarelix",
    "Lanreotide Acetate"
  ],
  "Targeted Small-Molecule Inhibitors": {
    "EGFR Inhibitors": [
      "Afatinib",
      "Erlotinib",
      "Gefitinib",
      "Osimertinib",
      "Rociletinib",
      "Icotinib"
    ],
    "ALK Inhibitors": [
      "Alectinib",
      "Brigatinib",
      "Ceritinib",
      "Crizotinib",
      "Lorlatinib",
      "Ensartinib",
      "Entrectinib"
    ],
    "BRAF/MEK Pathway Inhibitors": [
      "Dabrafenib",
      "Vemurafenib",
      "Cobimetinib",
      "Trametinib"
    ],
    "mTOR Inhibitor": [
      "Everolimus"
    ],
    "BTK Inhibitors": [
      "Ibrutinib",
      "Acalabrutinib"
    ],
    "JAK Inhibitor": [
      "Ruxolitinib Phosphate"
    ],
    "Multi-Kinase Inhibitors": [
      "Sorafenib Tosylate",
      "Sunitinib Malate",
      "Cabozantinib Smalate",
      "Neratinib",
      "Imatinib Mesylate",
      "Palbociclib"
    ]
  },
  "Antitumor Antibiotics": [
    "Doxorubicin Hydrochloride",
    "Epirubicin Hydrochloride",
    "Mitomycin"
  ],
  "Proteasome Inhibitors": [
    "Bortezomib",
    "Carfilzomib"
  ],
  "PARP Inhibitor": [
    "Olaparib"
  ],
  "Epigenetic Modifiers": [
    "Decitabine"
  ],
  "Other / Novel Mechanisms": [
    "Lurbinectedin",
    "Navitoclax",
    "Temozolomide",
    "Hydroxyurea",
    "Lenalidomide",
    "Pomalidomide"
  ]
}
